bordetella
pertussi
whoop
cough
vaccineprevent
diseas
still
remain
seriou
infect
neonat
young
infant
describ
two
young
infant
monozygot
twin
sever
b
pertussi
pneumonia
one
need
extracorpor
membran
oxygen
diagnost
workup
unexplain
hematuria
proteinuria
ill
reveal
low
serum
complement
compon
level
followup
level
remain
low
mgl
extens
analysi
persist
low
level
reveal
unknown
heterozyg
mutat
gene
sibl
mother
mutat
combin
specif
virul
mechan
b
pertussi
probabl
contribut
sever
diseas
cours
case
conclus
propos
genet
caus
complement
disord
consid
confront
sever
case
b
pertussi
infect
pertussi
also
known
whoop
cough
infecti
respiratori
diseas
caus
gramneg
bacillu
bordetella
pertussi
annual
million
case
pertussi
worldwid
mani
pertussisrel
death
year
occur
mostli
develop
countri
young
infant
sever
diseas
manifest
seen
neonat
young
infant
absenc
vaccin
partial
due
diminish
matern
deriv
protect
antibodi
although
matern
antibodi
b
pertussi
transport
across
placenta
shown
women
childbear
age
nowaday
lower
antibodi
childhood
diseas
lack
natur
booster
due
vaccin
result
renew
interest
matern
vaccin
prevent
neonat
pertussi
infect
preterm
neonat
gener
low
antibodi
concentr
found
compar
term
neonat
heining
et
al
recent
demonstr
preterm
infant
lower
antibodi
level
b
pertussi
increas
gestat
age
impli
greater
risk
pertussi
infect
born
prematur
report
describ
two
young
infant
monozygot
twin
born
prematur
sever
b
pertussi
pneumonia
complement
disord
detect
result
low
complement
compon
level
relat
defici
diseas
sever
caus
b
pertussi
discuss
femal
monochorion
diamniot
twin
born
gestat
age
week
day
preterm
prematur
ruptur
membran
celeston
given
h
birth
twin
good
start
apgar
score
twin
weigh
g
twin
b
weigh
g
postnat
develop
infant
respiratori
distress
syndrom
grade
ii
need
continu
posit
airway
pressur
otherwis
neonat
period
unremark
four
week
birth
discharg
hospit
good
clinic
condit
age
week
adjust
preterm
birth
week
twin
present
local
hospit
obstin
increas
cough
feed
difficulti
decreas
urin
product
without
fever
physic
examin
chest
reveal
crackl
sound
lung
laboratori
find
demonstr
leukocyt
count
l
normal
valu
age
l
lymphocyt
creactiv
protein
crp
mgl
normal
valu
age
mgl
chest
xray
show
increas
peribronchiolar
consolid
consolid
upper
lobe
left
lung
polymeras
chain
reaction
pcr
respiratori
syncyti
viru
parainfluenza
type
coronaviru
adenoviru
bocaviru
rhinoviru
human
metapneumoviru
influenza
b
neg
bacteri
pneumonia
suspect
treat
amoxicillin
oral
despit
therapi
cough
increas
day
recurr
episod
sever
paroxysm
cough
follow
apnea
bradycardia
although
continu
oxygen
flow
caffein
given
period
apnea
becam
frequent
sever
endotrach
intub
ventilatori
support
indic
transfer
nearest
pediatr
intens
care
unit
admiss
blood
test
result
show
leukocyt
count
l
lymphocyt
count
crp
mgl
chest
xray
show
bilater
diffus
infiltr
consolid
lung
antibiot
switch
amoxicillinclavulan
acid
administ
intraven
mean
time
pcr
b
pertussi
found
posit
sputum
twin
sister
twin
b
turn
posit
sputum
well
therefor
antibiot
regim
chang
amoxicillinclavulan
acid
azithromycin
period
low
oxygen
satur
becam
frequent
episod
bronchospasm
initi
respond
well
bronchodil
ultrasonographi
heart
reveal
pulmonari
hypertens
mean
arteri
pressur
mmhg
sign
tricuspid
insuffici
highfrequ
oscil
nitrogen
monoxid
ventil
need
need
extracorpor
membran
oxygen
ecmo
consid
transfer
pediatr
intens
care
unit
initi
improv
ventil
magnesium
sulfat
administ
intraven
pulmonari
condit
worsen
develop
sever
pulmonari
hypertens
therefor
ecmo
treatment
start
treatment
complic
sever
hypertens
pleura
exud
fluid
overload
treat
continu
venoven
hemofiltr
anoth
complic
origin
exactli
clear
ischem
stroke
brain
region
right
posterior
cerebr
arteri
watersh
cerebr
infarct
right
medial
cerebr
arteri
led
hemiparesi
hemianopsia
left
side
eventu
day
ecmo
therapi
need
pulmonari
condit
improv
ecmo
treatment
twin
develop
hematuria
rbc
per
highpow
field
proteinuria
mg
mmol
proteincreatinin
ratio
normal
valu
age
mg
mmol
red
cell
cast
suggest
glomerulonephr
howev
serum
creatinin
level
normal
valu
age
blood
pressur
mmhg
age
normal
extens
blood
urin
analysi
reveal
low
serum
complement
level
without
abnorm
tabl
girl
eventu
recov
discharg
month
intens
treatment
age
month
delay
psychomotor
develop
epilept
seizur
control
antiepilept
medic
twin
sister
twin
b
develop
sign
symptom
day
later
admit
pediatr
intens
care
unit
intub
respiratori
failur
ventilatori
support
caffein
need
week
treat
clarithromycin
develop
sign
glomerulonephr
addit
analysi
complement
factor
reveal
low
serum
level
well
twin
b
discharg
week
admiss
although
sever
display
less
dramat
diseas
cours
compar
twin
sister
could
explain
fact
b
pertussi
pcr
sputum
posit
earlier
stage
time
treatment
macrolid
commenc
followup
girl
show
normal
psychomotor
develop
age
month
followup
twin
serum
analysi
demonstr
persist
low
level
mgl
normal
level
mgl
shown
tabl
suggest
altern
complement
pathway
involv
genet
caus
suspect
parent
gave
permiss
studi
gene
encod
import
altern
complement
pathway
protein
factor
h
factor
membran
cofactor
protein
complement
factor
b
cfb
sibl
previous
unknown
delet
one
nucleotid
identifi
exon
gene
encod
mutat
caus
frameshift
lead
preliminari
stop
five
amino
acid
delet
domain
gray
domain
involv
cfb
bind
indic
imag
gener
use
pymol
protein
data
bank
file
protein
mutant
protein
almost
shorter
wildtyp
result
loss
import
bind
site
cfb
loss
thioester
bond
import
function
protein
fig
genom
dna
analysi
parent
show
matern
inherit
mother
twin
gener
healthi
recal
frequent
sick
suffer
upper
respiratori
tract
infect
child
mutat
probabl
lead
absent
secret
mutant
due
nonsensemedi
mrna
decay
indic
serum
level
half
normal
consequ
one
may
expect
mutat
lead
impair
complement
activ
system
congenit
defici
detect
monozygot
femal
twin
sever
b
pertussi
pneumonia
infanc
although
well
known
neonat
young
infant
increas
risk
develop
sever
whoop
cough
due
socal
immatur
immun
system
signific
abnorm
complement
pathway
relat
diseas
sever
describ
need
investig
complement
cascad
consist
classic
lectin
altern
pathway
converg
complement
activ
complement
cascad
lead
format
membran
attack
complex
mac
particular
microorgan
elimin
immun
system
whole
process
regul
differ
complement
inhibitor
promot
b
pertussi
gramneg
encapsul
bacteri
strain
microcapsul
protect
complement
attack
b
pertussi
abl
bind
classic
pathway
inhibitor
protein
esteras
inhibitor
altern
pathway
inhibitor
factor
h
evad
complement
system
way
protect
make
possibl
colon
host
final
remark
persist
low
level
patient
led
us
examin
major
altern
complement
pathway
protein
genom
level
newli
found
mutat
possibl
caus
lack
secret
therefor
reason
persist
decreas
serum
level
consequ
caus
less
format
mac
bacteria
therefor
lead
impair
elimin
b
pertussi
conclus
sever
case
infantil
b
pertussi
pneumonia
prematur
born
twin
might
well
caus
mutat
gene
result
defici
level
serum
addit
immatur
immun
system
accordingli
one
consid
screen
abnorm
complement
protein
level
confront
sever
infect
b
pertussi
pathogen
evad
complement
system
use
similar
mechan
underli
genet
caus
complement
disord
might
present
